Viewing Study NCT04636008


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-29 @ 1:45 PM
Study NCT ID: NCT04636008
Status: RECRUITING
Last Update Posted: 2024-08-06
First Post: 2020-11-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Sponsor: West China Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module